TGTX earnings
TG Therapeutics (TGTX) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
TGTX earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2026 | Aug 3, 2026 | 0.05 | 0.31 | -83.64% | $240.34M |
| Q1 2026 | May 6, 2026 | 0.14 | 0.23 | -39.13% | $204.92M |
| Q4 2025 | Feb 26, 2026 | 0.14 | 0.35 | -60.00% | $192.57M |
| Q3 2025 | Nov 3, 2025 | 2.43 | 0.24 | 912.50% | $161.71M |
| Q2 2025 | Aug 4, 2025 | 0.17 | 0.32 | -46.88% | $141.15M |
| Q1 2025 | May 5, 2025 | 0.03 | 0.18 | -83.33% | $120.86M |
| Q4 2024 | Mar 3, 2025 | 0.15 | 0.08 | 87.50% | $108.19M |
| Q3 2024 | Nov 4, 2024 | 0.02 | 0.03 | -33.33% | $83.88M |
| Q2 2024 | Aug 6, 2024 | 0.04 | -0.05 | 180.00% | $73.47M |
| Q1 2024 | May 1, 2024 | -0.07 | -0.04 | -96.02% | $63.47M |
| Q4 2023 | Feb 28, 2024 | -0.09 | -0.12 | 25.00% | $43.97M |
| Q3 2023 | Nov 1, 2023 | 0.73 | 0.12 | 508.33% | $165.81M |
| Aug 1, 2023 | -0.34 | -0.26 | -30.77% | – | |
| May 1, 2023 | -0.28 | -0.36 | 22.22% | – | |
| Feb 28, 2023 | -0.39 | -0.26 | -50.00% | – | |
| Nov 10, 2022 | -0.26 | -0.33 | 21.21% | – | |
| Aug 8, 2022 | -0.30 | -0.49 | 38.78% | – | |
| May 10, 2022 | -0.51 | -0.55 | 7.27% | – | |
| Mar 1, 2022 | -0.70 | -0.62 | -12.90% | – | |
| Nov 4, 2021 | -0.65 | -0.56 | -16.07% | – |
- TGTX reports next on Nov 2, 2026, with EPS of 0.37 expected.
- TGTX beat EPS estimates in 24 of its last 62 reports.
Updated 2026-11-02 19:55 UTC